Center for Computational Imaging and Personalized Diagnostics researchers awarded two patents on January 26, 2021

“Predicting pathological complete response to neoadjuvant chemotherapy from baseline breast dynamic contrast enhanced magnetic resonance imaging (DCE-MRI)” and “Predicting response to immunotherapy using computer extracted features relating to spatial arrangement of tumor infiltrating lymphocytes in non-small cell lung cancer”.

Read the article.